Annie Park Moseman
About Annie Park Moseman
Annie Park Moseman is a Post Doctoral Fellow at the National Institutes of Health, specializing in the development of a live-attenuated vaccine for Respiratory Syncytial Virus within the RNA viruses section of the Laboratory of Infectious Diseases.
Work at National Institutes of Health
Annie Park Moseman has been serving as a Post Doctoral Fellow at the National Institutes of Health (NIH) since 2013. She is part of the RNA viruses section within the Laboratory of Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Her research primarily focuses on the development of a live-attenuated vaccine for Respiratory Syncytial Virus (RSV), contributing to advancements in infectious disease prevention.
Education and Expertise
Annie Park Moseman holds a Doctor of Philosophy degree, which she earned from Tufts University between 2007 and 2013. Her academic background includes a focus on Immunology and Philosophy. Prior to her doctoral studies, she completed her Bachelor of Arts in Biology at Carleton College from 1999 to 2003. This educational foundation supports her expertise in the field of infectious diseases and vaccine development.
Background
Annie Park Moseman began her higher education at Carleton College, where she studied Biology, laying the groundwork for her future research endeavors. She then pursued advanced studies at Tufts University, where she earned her PhD. Since 2013, she has been engaged in postdoctoral research at NIH, specifically in the area of RNA viruses, which has shaped her professional trajectory in the biomedical field.
Research Focus
In her current role at the NIH, Annie Park Moseman is involved in critical research aimed at developing a live-attenuated vaccine for Respiratory Syncytial Virus (RSV). This work is significant in the context of public health, as RSV is a major cause of respiratory illness in infants and young children. Her contributions to the RNA viruses section of the Laboratory of Infectious Diseases are essential for advancing knowledge and potential treatment options for viral infections.